137 related articles for article (PubMed ID: 10627636)
1. Mini-ICE regimen as mobilization therapy for chronic myelogenous leukaemia patients at diagnosis.
Sureda A; Petit J; Brunet S; Boqué C; Aventín A; Martino R; González JR; Amill B; Larriba I; Blanco A; Martín-Henao GA; Sierra J; Grañena A
Bone Marrow Transplant; 1999 Dec; 24(12):1285-90. PubMed ID: 10627636
[TBL] [Abstract][Full Text] [Related]
2. High-dose chemo-radiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia.
Carella AM; Chimirri F; Podestà M; Pitto A; Piaggio G; Dejana A; Lerma E; Pollicardo N; Vassallo F; Soracco M; Benvenuto F; Valbonesi M; Carlier P; Vimercati R; Prencipe E; Gatti AM; Ferrara RA; Incagliato M; Florio G; Frassoni F
Bone Marrow Transplant; 1996 Feb; 17(2):201-5. PubMed ID: 8640167
[TBL] [Abstract][Full Text] [Related]
3. Collection of Philadelphia-negative stem cells using recombinant human granulocyte colony-stimulating factor in chronic myeloid leukemia patients treated with alpha-interferon.
Hernández-Boluda JC; Carreras E; Cervantes F; Marín P; Arellano-Rodrigo E; Rovira M; Solé F; Lloveras E; Espinet B; Ocejo A; Montserrat E
Haematologica; 2002 Jan; 87(1):17-22. PubMed ID: 11801461
[TBL] [Abstract][Full Text] [Related]
4. Mobilization of peripheral stem cells with intensive chemotherapy (ICE regimen) and G-CSF in chronic myeloid leukemia.
Boqué C; Petit J; Sarrá J; Cancelas JA; Muñoz J; Español JI; de la Banda E; Aventin A; Berlanga J; Ferrá C; Amill B; Torrico C; Azqueta C; Llucià M; García J; Grañena A
Bone Marrow Transplant; 1996 Nov; 18(5):879-84. PubMed ID: 8932840
[TBL] [Abstract][Full Text] [Related]
5. Collection of Ph-negative progenitor cells from interferon responsive patients with chronic myeloid leukemia: effect of granulocyte-colony-stimulating factor mobilization.
Olavarria E; Parker S; Craddock C; Philpott N; Tiniakou M; Chase A; Kanfer E; Apperley JF; Goldman JM
Haematologica; 2000 Jun; 85(6):647-52. PubMed ID: 10870123
[TBL] [Abstract][Full Text] [Related]
6. Collection of 'normal' blood repopulating cells during early hemopoietic recovery after intensive conventional chemotherapy in chronic myelogenous leukemia.
Carella AM; Podesta M; Frassoni F; Raffo MR; Pollicardo N; Pungolino E; Vimercati R; Sessarego M; Parodi C; Rabitti C
Bone Marrow Transplant; 1993 Sep; 12(3):267-71. PubMed ID: 7694724
[TBL] [Abstract][Full Text] [Related]
7. Autologous transplantation with Philadelphia-negative progenitor cells for patients with chronic myeloid leukaemia (CML) failing to attain a cytogenetic response to alpha interferon.
McBride NC; Cavenagh JD; Newland AC; Lillington DM; Murrell C; Kelsey SM
Bone Marrow Transplant; 2000 Dec; 26(11):1165-72. PubMed ID: 11149726
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors influencing feasibility of cytogenetic and molecular analysis in leukapheresis products in chronic myelogenous leukemia patients.
Carrasco M; Sureda A; Martínez C; Carmona M; Altés A; Martín-Henao GA; Aventín A; Sierra J
Ann Hematol; 2002 Dec; 81(12):710-6. PubMed ID: 12483367
[TBL] [Abstract][Full Text] [Related]
9. Myelosuppressive chemotherapy to mobilize normal stem cells in chronic myeloid leukemia.
Mehta J; Mijović A; Powles R; Pagliuca A; Singhal S; Czepulkowski B; Swansbury GJ; Treleaven J; Mufti GJ
Bone Marrow Transplant; 1996 Jan; 17(1):25-9. PubMed ID: 8673050
[TBL] [Abstract][Full Text] [Related]
10. Peripheral blood progenitor cell collection in chronic myeloid leukemia patients with complete cytogenetic response after treatment with imatinib mesylate.
Perseghin P; Gambacorti-Passerini C; Tornaghi L; Dassi M; Pioltelli P; Parma M; Colnaghi F; Giudici G; Elli E; Fumagalli M; Ponchio L; Biondi A; Pogliani EM
Transfusion; 2005 Jul; 45(7):1214-20. PubMed ID: 15987369
[TBL] [Abstract][Full Text] [Related]
11. Ifosfamide- and etoposide-based chemotherapy as salvage and mobilizing regimens for poor prognosis lymphoma.
Mayer J; Vásová I; Korístek Z; Navrátil M; Klabusay M; Doubek M; Vorlícek J; Cernilová I; Vodvárka P; Petráková K
Eur J Haematol Suppl; 2001 Jul; 64():21-7. PubMed ID: 11486396
[TBL] [Abstract][Full Text] [Related]
12. Mobilisation of haemopoietic progenitors in CML: a second course of intensive chemotherapy does not improve Ph-negativity in stem cell harvests.
Janssen JJ; van Rijn RS; van der Holt B; Schuurhuis GJ; Vellenga E; Verhoef GE; Ossenkoppele GJ; van den Berg E; Hagemeijer A; Släter R; Nieuwint AW; Cornelissen JJ
Bone Marrow Transplant; 2000 Jun; 25(11):1147-55. PubMed ID: 10849527
[TBL] [Abstract][Full Text] [Related]
13. Mini-ICE regimen allows mobilization of peripheral blood progenitor cells in a patient with chronic myelogenous leukemia failing the ICE protocol.
Salar A; Sureda A; Menéndez B; Sierra J
Haematologica; 2000 Mar; 85(3):326-7. PubMed ID: 10702830
[No Abstract] [Full Text] [Related]
14. Chemotherapy-induced mobilization of karyotypically normal PBSC for autografting in CML.
Fischer T; Neubauer A; Mohm J; Huhn D; Busemann C; Link H; Arseniev L; Büssing B; Novotny J; Ganser A; Duyster J; Bunjes D; Kreiter S; Aulitzky W; Hehlmann R; Huber C
Bone Marrow Transplant; 1998 May; 21(10):1029-36. PubMed ID: 9632277
[TBL] [Abstract][Full Text] [Related]
15. [Autologous transplantation of Ph-negative peripheral blood stem cells for treatment of chronic myelogenous leukemia].
Hatsuse M; Okano A; Okamoto A; Shimura K; Takahashi R; Hirai H; Ashihara E; Inaba T; Fujita N; Shimazaki C; Nakagawa M
Rinsho Ketsueki; 2000 Aug; 41(8):671-5. PubMed ID: 11020996
[TBL] [Abstract][Full Text] [Related]
16. [Autogeneic peripheral blood hemopoietic stem cell transplantation for chronic myeloid leukemia with imatinib mesylate-induced negative Philadelphia chromosome].
Meng FY; Sun J; Liu QF; Xu D; Yang LJ; Song LL; Liu XL; Xu B; Zhou SY
Di Yi Jun Yi Da Xue Xue Bao; 2003 Dec; 23(12):1301-2, 1306. PubMed ID: 14678896
[TBL] [Abstract][Full Text] [Related]
17. Preliminary results of stem cell mobilization in chronic myeloid leukemia with a moderate intensity chemotherapy regimen and G-CSF or G-CSF plus IL-3.
Aulitzky WE; Neubauer A; Kolbe K; Schneller F; Busemann C; Schleiermacher E; Peschel C; Siegert W; Huber C; Huhn D
Bone Marrow Transplant; 1996 May; 17 Suppl 3():S67-9. PubMed ID: 8769707
[TBL] [Abstract][Full Text] [Related]
18. Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignancies.
Cao TM; Kusnierz-Glaz C; Valone F; Stockerl-Goldstein KE; Hu WW; Johnston L; Blume KG; Strober S; Negrin RS
Cancer; 2001 Jun; 91(12):2205-13. PubMed ID: 11413507
[TBL] [Abstract][Full Text] [Related]
19. Effective progenitor cell mobilization in lymphoproliferative disorders using ifosfamide, epirubicin and etoposide (IEV).
O'Connell N; Gardiner N; Duggan C; Enright H; Kennedy MJ; McCann SR; Daly PA; Browne PV
Eur J Haematol Suppl; 2001 Jul; 64():33-6. PubMed ID: 11486399
[TBL] [Abstract][Full Text] [Related]
20. Mobilization of peripheral blood stem cells following myelosuppressive chemotherapy: a randomized comparison of filgrastim, sargramostim, or sequential sargramostim and filgrastim.
Weaver CH; Schulman KA; Buckner CD
Bone Marrow Transplant; 2001 May; 27 Suppl 2():S23-9. PubMed ID: 11436117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
